Delivery Order SPE2DB20D3303-SPE2DB24FA3GT

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,789.83 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of APTIOM 600 MG TABLET 60S, a prescription medication, with a period of performance through March 18, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) awarded solely to...
This federal contract award, valued at $3,786.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APTIOM 400 MG TABLET 30S, a medication, with an ultimate completion date of October 13, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,076.20 contract is for the delivery of APTIOM 600 MG TABLETs to support federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of April 26, 2023. This award is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $22,343.60 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of APTIOM 400 MG TABLET 30S, a pharmaceutical product, with a completion date of November 17, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide APTIOM 600 MG TABLET 60S, a pharmaceutical product. The contract has a potential value of $1,423.54 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,704.87 firm fixed price delivery order is for the supply of APTIOM 400 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of June 11, 2024 and was awarded on June 10, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,170.15, is for the delivery of APTIOM 800 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,273.71, is for the delivery of APTIOM 400 MG TABLET 30S, a prescription medication. It is a firm fixed-price contract with a completion date of January 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,536.59 fixed-price delivery order is for the supply of APTIOM 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,749.52 firm-fixed-price delivery order is for the supply of APTIOM 800 MG TABLET 30S, a branded pharmaceutical product. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA3GT
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply APTIOM 600 MG TABLET 60S, a prescription medication. The contract, valued at $1,406.67, has a completion date of September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/19/24, 9:11 AM